This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Janet C. Nevins | |
|---|---|
| Name | Janet C. Nevins |
| Birth date | (unknown) |
| Nationality | American |
| Fields | Virology; Cell Biology; Cancer Research |
| Institutions | Massachusetts Institute of Technology; Harvard University; Dana–Farber Cancer Institute |
| Alma mater | Wellesley College; Harvard Medical School |
Janet C. Nevins is an American biomedical scientist known for contributions to viral oncology, cell cycle regulation, and transcriptional control in cancer. Her work spans molecular virology, transcriptional regulation, and cancer biology, with influence on studies at institutions such as Massachusetts Institute of Technology, Harvard Medical School, Dana–Farber Cancer Institute, and collaborations involving researchers from Cold Spring Harbor Laboratory, Sloan Kettering Institute, and National Institutes of Health. Nevins’s research has interfaced with studies on oncogenic viruses like adenovirus, human papillomavirus, and model systems connected to pathways studied in p53, RB1, and MYC research.
Nevins completed undergraduate studies at Wellesley College and pursued graduate and medical training at Harvard Medical School and affiliated research programs. During her formative training she engaged with laboratories that intersected with investigators from Columbia University, Yale University, and Stanford University programs studying viral transformation, cellular proliferation, and tumor suppressor pathways. Her early mentors and collaborators included faculty connected to laboratories at Massachusetts General Hospital and institutes that had close ties to seminal work by researchers associated with Rosalind Franklin-era molecular virology, Howard Temin-related reverse transcription concepts, and scholarship from groups influenced by David Baltimore and Howard M. Temin legacies.
Nevins held faculty and research positions at major biomedical centers, contributing to cross-disciplinary teams at Harvard University and the Dana–Farber Cancer Institute. Her laboratory emphasized mechanistic studies of viral oncoproteins, host transcription factors, and cell cycle regulators, interacting with research threads traced to laboratories of Harvey Lodish, Bruce Stillman, and Joan Steitz. She collaborated broadly with investigators from Whitehead Institute, Broad Institute, Cold Spring Harbor Laboratory, and clinical investigators affiliated with Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center on translational aspects of oncogenic signaling. Nevins’s career included mentorship of trainees who later joined departments at University of California, San Francisco, Johns Hopkins University, and University of Chicago, maintaining networks with researchers at Princeton University and Yale University working on transcriptional networks and chromatin biology.
Nevins made major contributions to understanding how viral proteins and cellular transcriptional regulators coordinate cell proliferation and oncogenesis. Her studies connected viral oncogenes with host factors implicated in the E2F family of transcription factors, pathways interacting with RB1 tumor suppressor studies, and downstream targets overlapping with MYC and p53 research. She published influential papers elucidating mechanisms of transcriptional control by E2F-related complexes, the interplay between cyclin-dependent kinases and transcriptional programs highlighted in work related to CDK4 and CDK2, and the role of chromatin-associated regulators linked to investigations at Salk Institute and Howard Hughes Medical Institute laboratories.
Her publications appeared in leading journals known for publishing landmark studies alongside work from authors affiliated with Nature, Science, Cell, and specialized outlets similar to Proceedings of the National Academy of Sciences (PNAS), reflecting integration with discoveries emerging from Cold Spring Harbor-affiliated studies and consortium-style efforts akin to those seen at the ENCODE project. Nevins’s papers frequently cited and were cited by research groups investigating transcriptional circuitry in cancer at Memorial Sloan Kettering Cancer Center, Fred Hutchinson Cancer Center, and university laboratories related to Stanford University School of Medicine.
Over her career, Nevins received recognition from scientific societies and research organizations; she served on advisory panels and editorial boards tied to institutions such as National Institutes of Health study sections and committees connected to American Association for Cancer Research and organizations analogous to American Society for Cell Biology. She held fellowships and visiting appointments that fostered collaborations with centers like Scripps Research Institute and international partners associated with Max Planck Society labs and European cancer research centers. Nevins’s roles included leadership positions in departmental governance at Harvard Medical School-affiliated programs and participation in review panels alongside investigators from NIH, Wellcome Trust, and foundation-funded initiatives grouping researchers from University College London and Karolinska Institutet.
Nevins’s legacy encompasses mentorship of a generation of scientists who advanced research at institutions including Columbia University Irving Medical Center, University of Pennsylvania, and University of California, Berkeley. Her trainees and collaborators have gone on to contribute to biomedical advances at companies and centers such as Genentech, Amgen, Pfizer, and translational programs associated with Broad Institute-industry partnerships. Her scientific lineage continues in laboratories that examine transcriptional control, viral oncology, and cell-cycle regulation, often in dialogue with contemporary efforts at MIT Koch Institute and cancer centers like MD Anderson Cancer Center. The methods, conceptual frameworks, and collaborative networks she helped build remain influential in studies addressing oncogenic transcriptional networks and molecular therapeutics development.
Category:American virologists Category:Women biologists